About half of children who did egg oral immunotherapy (OIT) were able to consume some form of egg five years… Read more »
Search Results for: OIT
AAAAI 2019: Expert Shines Light on Novel Therapies Under Study for Food Allergy
The FDA is considering approval of the AR101 peanut immunotherapy and will soon evaluate the Viaskin Peanut patch. But if… Read more »
Allergic Living’s Research Highlights from the AAAAI 2019 Conference
At the American Academy of Allergy, Asthma & Immunology held in San Francisco in late February, thousands of allergists and… Read more »
How Do They Do It? Families Juggle Celiac Disease – Plus Food Allergies
Meet 3 families who juggle celiac disease, food allergies and sometimes more in one household. At first glance, Noah Joseph… Read more »
Aimmune Applies to Move Forward on Testing Novel Egg Allergy Treatment
Aimmune Therapeutics, the company behind the AR101 oral immunotherapy (OIT) treatment for peanut allergy, announced on Dec. 20, 2018 that… Read more »
Food Allergy $200 Million Fundraising Campaign: Why Now and What are the Goals?
On Dec. 4, Food Allergy Research & Education (FARE) announced the most ambitious fundraising campaign to date for food allergy.… Read more »
Xolair Gains “Breakthrough” Status to Be Developed as Food Allergy Treatment
The FDA has given its “breakthrough therapy designation” to omalizumab, known by the brand Xolair, to be developed as a… Read more »
Allergists Excited for Peanut Therapy That’s in Line for Approval
Hundreds of allergists turned out to see Dr. Stacie Jones present highly anticipated study results at the AAAAI/WAO joint congress… Read more »
Parents Seen Taking Big Food Allergy Risks with Their Kids in New York Study
A study of New York City parents identified 44 percent of parents taking significant risks in managing their kids’ food… Read more »
Baby Meets Risky Foods: Parents Struggle to Adapt to New Food Allergy Guidelines
New guidelines suggest that feeding allergenic foods to at-risk infants plays an important role in allergy prevention. But at home… Read more »